The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Meningococcal Disease: Still with Us
Abstract
In spite of considerable success in the development of drugs and vaccines, the problem of disease due to Neisseria meningitidis is far from solved. As late as the 1970s, epidemics of meningococcal disease occurred in at least 30 countries in all parts of the world. Most of the epidemics were caused by group A organisms, but epidemics due to groups B and C also took place occasionally. The case/fatality rate was usually less than 10% among patients with true meningitis; among those with "pure" septicemia, it was as high as 70%. Children less than five years old are most prone to meningococcal disease, but mortality is often highest among young adults. Because close contacts of the index case are at considerable risk--at least several hundred times higher than in the rest of the population--they should be protected immediately with an appropriate antibiotic and, if possible, with a vaccine as well. At the present time, however, no vaccine is available for use against group B organisms, which in nonepidemic conditions are the most prevalent of all meningococci.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,411
HUMAN IMMUNITY TO THE MENINGOCOCCUS
Goldschneider, I., Gotschlich, E. C., & Artenstein, M. S. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.6.1307 · Cited by 1,294
HUMAN IMMUNITY TO THE MENINGOCOCCUS
Goldschneider, I., Gotschlich, E. C., & Artenstein, M. S. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.6.1327 · Cited by 995
Steroids in the Treatment of Clinical Septic Shock
SCHUMER, W. (1976) · Annals of Surgery · doi:10.1097/00000658-197609000-00011 · Cited by 545
PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES
MacLeod, C. M., Hodges, R. G., Heidelberger, M., & Bernhard, W. G. (1945) · Journal of Experimental Medicine · doi:10.1084/jem.82.6.445 · Cited by 518
HUMAN IMMUNITY TO THE MENINGOCOCCUS
Gotschlich, E. C., Goldschneider, I., & Artenstein, M. S. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.6.1367 · Cited by 402
Prevention of Meningococcal Disease by Group C Polysaccharide Vaccine
Artenstein, M. S., Gold, R., Zimmerly, J. G., Wyle, F. A., Schneider, H., & Harkins, C. (1970) · New England Journal of Medicine · doi:10.1056/nejm197002192820803 · Cited by 369
Peltola, H., Mäkelä, P. H., Käyhty, H., Jousimies, H., Herva, E., Hällström, K., Sivonen, A., Renkonen, O.-V., Pettay, O., Karanko, V., et al. (1977) · New England Journal of Medicine · doi:10.1056/nejm197709292971302 · Cited by 344
Self-citationFothergill, L. D., & Wright, J. (1933) · The Journal of Immunology · Cited by 334
Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants.
Gold, R., Lepow, M. L., Goldschneider, I., Draper, T. L., & Gotschlich, E. C. (1975) · Journal of Clinical Investigation · doi:10.1172/jci108235 · Cited by 235
Cited by
ANTIGENIC SIMILARITIES BETWEEN BRAIN COMPONENTS AND BACTERIA CAUSING MENINGITIS
Finne, J., Leinonen, M., & Mäkelä, P. H. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90340-9 · Cited by 796
Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
van Deuren, M., Brandtzaeg, P., & van der Meer, J. W. M. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.1.144 · Cited by 588
Infections of People with Complement Deficiencies and Patients Who Have Undergone Splenectomy
Ram, S., Lewis, L. A., & Rice, P. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00048-09 · Cited by 405
Meningococcal carriage and disease—Population biology and evolution
Caugant, D. A., & Maiden, M. C. J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.061 · Cited by 381
Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil
Cassio de Moraes, J., Camargo, M. C. C., Rossetto Hidalgo, N. T., Aparecida Barbosa, H., Gattas, V. L., Vasconcelos, H. D. G., Tavares Sacchi, C., Land Gral, I. M., Perkins, B. A., Wenger, J. D., et al. (1992) · The Lancet · doi:10.1016/0140-6736(92)93086-3 · Cited by 366
Feil, E. J., Maiden, M. C., Achtman, M., & Spratt, B. G. (1999) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a026061 · Cited by 293
Population genetics and molecular epidemiology of Neisseria meningitidis
CAUGANT, D. A. (1998) · APMIS · doi:10.1111/j.1699-0463.1998.tb01379.x · Cited by 255
Etiology and Mortality of Bacterial Meningitis in Northeastern Brazil
Bryan, J. P., de Silva, H. R., Tavares, A., Rocha, H., & Scheld, W. M. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.1.128 · Cited by 105
The spectrum of acute bacterial meningitis in elderly patients
Domingo, P., Pomar, V., de Benito, N., & Coll, P. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-108 · Cited by 74
Berg, S., Trollfors, B., Claesson, B. A., Alestig, K., Gothefors, L., Hugosson, S., Lindquist, L., Olcén, P., Romanus, V., & Strangert, K. (1996) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549609027166 · Cited by 36
Three days of intravenous benzyl penicillin treatment of meningococcal disease in adults
Ellis-Pegler, R., Galler, L., Roberts, S., Thomas, M., & Woodhouse, A. (2003) · Clinical Infectious Diseases · doi:10.1086/377203 · Cited by 35
Oftung, F., Løvik, M., Andersen, S. R., Frøholm, L. O., & Bjune, G. (1999) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.1999.tb01374.x · Cited by 21
Metadata
- Authors
- Peltola, H.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1983-01-01
- Volume
- 5
- Issue
- 1
- Pages
- 71-91
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2167896356
- Cited by
- 394
- References
- 40
- FWCI
- 12.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.